SCIE
SpectraScience Inc
Price:  
0.00 
USD
Volume:  
435,070.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SCIE WACC - Weighted Average Cost of Capital

The WACC of SpectraScience Inc (SCIE) is 4.2%.

The Cost of Equity of SpectraScience Inc (SCIE) is 230.10%.
The Cost of Debt of SpectraScience Inc (SCIE) is 5.50%.

Range Selected
Cost of equity 2.80% - 457.40% 230.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 3.0% - 5.4% 4.2%
WACC

SCIE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta -116.85 -14.99
Additional risk adjustments 536.5% 537.0%
Cost of equity 2.80% 457.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1551.61 1551.61
Cost of debt 4.00% 7.00%
After-tax WACC 3.0% 5.4%
Selected WACC 4.2%

SCIE's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SCIE:

cost_of_equity (230.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (-116.85) + risk_adjustments (536.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.